Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
NKTR

Nektar

$21.87

0.48 (2.24%)

04:55
09/22/17
09/22
04:55
09/22/17
04:55
Conference/Events
Nektar management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 25

    Sep

Wednesday
NKTR

Nektar

$21.75

-0.85 (-3.76%)

10:44
09/20/17
09/20
10:44
09/20/17
10:44
Conference/Events
Nektar management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 25

    Sep

NKTR

Nektar

$21.75

-0.85 (-3.76%)

, BMY

Bristol-Myers

$62.93

0.23 (0.37%)

07:32
09/20/17
09/20
07:32
09/20/17
07:32
Hot Stocks
Nektar to present new data on immuno-oncology portfolio at SITC Meeting »

Nektar (NKTR) will…

NKTR

Nektar

$21.75

-0.85 (-3.76%)

BMY

Bristol-Myers

$62.93

0.23 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 24

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 18

    Oct

  • 26

    Oct

  • 09

    Nov

  • 05

    Mar

Over a week ago
NKTR

Nektar

$21.83

-0.44 (-1.98%)

09:03
09/12/17
09/12
09:03
09/12/17
09:03
Hot Stocks
Nektar begins dosing in PROPEL clinical study »

Nektar Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

NKTR

Nektar

$21.67

-0.06 (-0.28%)

18:16
09/06/17
09/06
18:16
09/06/17
18:16
Hot Stocks
Nektar's NKTR-181 gets FDA fast track designation for treatment of chronic pain »

Nektar Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

Over a month ago
NKTR

Nektar

$19.64

-0.61 (-3.01%)

16:15
08/08/17
08/08
16:15
08/08/17
16:15
Earnings
Nektar reports Q2 EPS (39c), consensus (37c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

NKTR

Nektar

$20.03

-0.01 (-0.05%)

07:11
08/07/17
08/07
07:11
08/07/17
07:11
Initiation
Nektar initiated at H.C. Wainwright »

Nektar initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

NKTR

Nektar

$22.95

0.71 (3.19%)

, LLY

Eli Lilly

$84.74

0.08 (0.09%)

06:45
07/25/17
07/25
06:45
07/25/17
06:45
Recommendations
Nektar, Eli Lilly analyst commentary at Jefferies »

Jefferies views Nektar…

NKTR

Nektar

$22.95

0.71 (3.19%)

LLY

Eli Lilly

$84.74

0.08 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 11

    Sep

NKTR

Nektar

$22.24

0.07 (0.32%)

08:00
07/24/17
07/24
08:00
07/24/17
08:00
Hot Stocks
Breaking Hot Stocks news story on Nektar 

Nektar trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$84.66

-0.09 (-0.11%)

, NKTR

Nektar

$22.24

0.07 (0.32%)

07:34
07/24/17
07/24
07:34
07/24/17
07:34
Hot Stocks
Eli Lilly and Nektar announce collaboration to develop NKTR-358 »

Eli Lilly and Company…

LLY

Eli Lilly

$84.66

-0.09 (-0.11%)

NKTR

Nektar

$22.24

0.07 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 11

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.